arrow
返回

The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability

delete2020-02-12
delete8
delete
OA
AI
T
Tao Xie
H
Hui Fang
W
Weiming Ouyang
P
Phillip Angart
M
Meng‐Jung Chiang
A
Ashwinkumar Bhirde
F
Faruk Sheikh
P
Patrick M. Lynch
A
Ankit Shah
S
Sharadrao M. Patil
K
Kang Chen
M
Meiyu Shen
C
Cyrus Agarabi
R
Raymond P. Donnelly
K
Kurt Brorson
S
Sarah J. Schrieber
K
Kristina E. Howard
S
Sarah Rogstad
D
David M. Frucht *
DOI:10.1038/s41598-020-59346-zdelete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
PEGylated recombinant human granulocyte colony stimulating factor (pegfilgrastim) is used clinically to accelerate immune reconstitution following chemotherapy and is being pursued for biosimilar development. One challenge to overcome in pegfilgrastim biosimilar development is establishing pharmacokinetic (PK) similarity, which is partly due to the degree of PK variability. We herein report that commercially available G-CSF and PEG ELISA detection kits have different capacities to detect pegfilgrastim aggregates that rapidly form in vitro in physiological conditions. These aggregates can be observed using SDS-PAGE, size-exclusion chromatography, dynamic light scattering, and real-time NMR analysis and are associated with decreased bioactivity as reflected by reduced drug-induced cellular proliferation and STAT3 phosphorylation. Furthermore, individual variability in the stability and detectability of pegfilgrastim in human sera is also observed. Pegfilgrastim levels display marked subject variability in sera from healthy donors incubated at 37 degrees C. The stability patterns of pegfilgrastim closely match the stability patterns of filgrastim, consistent with a key role for pegfilgrastim's G-CSF moiety in driving formation of inactive aggregates. Taken together, our results indicate that individual variability and ELISA specificity for inactive aggregates are key factors to consider when designing and interpreting studies involving the measurement of serum pegfilgrastim concentrations.
Keyword:
COLONY-STIMULATING FACTOR
G-CSF
PHARMACOKINETICS
PHARMACODYNAMICS
OXIDATION
PROTEIN
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Scientific Reports 封面图
Scientific Reports
IF:
3.9
论文数:
28.0W
被引数:
83.5W

机构

U
us food & drug administration (fda)
学者数:
1.4W
论文数: 9.3K
被引数: 3
引用论文

引用论文

Response
err1993-10-01
err0
PREAI
errLAWRENCE G. MILLER
err分享
err收藏
Automating RTOG-defined target volumes for postmastectomy radiation therapy
err2011-04-01
err0
PREAI
errHiral P. Fontanilla; Wendy A. Woodward; Mary E. Lindberg; Lifei Zhang; Hadley J. Sharp; Eric A. Strom; Mohammad Salehpour; Thomas A. Buchholz; Lei Dong
err分享
err收藏
Comparing Unstructured Adaptive Mesh Solutions for the High Lift Common Research Airfoil
err2021-09-01
err0
PREAI
errTodd Michal; Joshua Krakos; Dmitry Kamenetskiy; Marshall Galbraith; Carmen-Ioana Ursachi; Michael A. Park; W. Kyle Anderson; Frederic Alauzet; Adrien Loseille
err分享
err收藏
A sensitive WST-8-based bioassay for PEGylated granulocyte colony stimulating factor using the NFS-60 cell line
err2014-11-25
err14
errOAAI
errTiwari, Krishna; Wavdhane, Madan; Haque, Shafiul; Govender, Thavendran; Kruger, Hendrik G.; Mishra, Maheshwari K.; Chandra, Ramesh; Tiwari, Dileep
err分享
err收藏
G-CSF and GM-CSF in Neutropenia
err2015-08-15
err287
errOAAI
errMehta, Hrishikesh M.; Malandra, Michael; Corey, Seth J.
err分享
err收藏
High-Throughput In-Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm-Driven Dynamic Light Scattering
err2018-08-01
err13
PREAI
errBhirde, Ashwinkumar A.; Chiang, Meng-Jung; Venna, Ramesh; Beaucage, Serge; Brorson, Kurt
err分享
err收藏
A new type single-phase spindle motor for HDD and DVD
err1999-03-01
err0
PREAI
errD.R. Huang; C.Y. Fan; S.J. Wang; H.P. Pan; T.F. Ying; C.M. Chao; E.G. Lean
err分享
err收藏
学者 查看更多内容